ProCE Banner Activity

COVID-19: Which Drug, When, and Why? Antiviral Agents

Slideset Download
Downloadable slideset including the latest data on the use of antiviral agents for the treatment of COVID-19.

Released: April 25, 2022

Expiration: April 24, 2023

No longer available for credit.

Share

Faculty

David Alain Wohl

David Alain Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

David Alain Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

David A. Wohl, MD, has disclosed that he has received funds for research support from Gilead Sciences and Merck and consulting fees from Gilead Sciences, Janssen, Merck, and ViiV.